Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × NETWORK × Breast × Clear all

Phase

Phase 3 75 Phase 2 62 Phase NA 38 Phase 1 12 Phase 1/2 10 Phase EARLY_PHASE1 1 Phase 2/3 1

Status

Sponsor Class

OTHER 80 INDUSTRY 24 OTHER_GOV 3 UNKNOWN 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 7 Gastrointestinal 4 Other hematologic neoplasm 3 Lymphoid 3 Genitourinary 2 Sarcoma 1 Plasma cell 1 Other solid neoplasm 1 Head & Neck 1 Gynecologic 1 Dermatologic 1 CNS 1 Breast 1

Conditions

Breast Neoplasms 1

Interventions

Vinorelbine 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00049660 2012-07-18

Capecitabine Compared With Vinorelbine in Treating Women With Metastatic Breast Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2/3 Terminated

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡